铁菌在骨髓瘤免疫治疗中的协同作用
Dongliang Tian1, Zhaofei Yang1, Jun Zhang1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Medical oncology (Northwood, London, England)
|December 24, 2025
概括
作为细胞死亡途径的铁灭,通过克服药物耐药性和增强抗瘤免疫力来治疗侵略性骨髓瘤 (OS) 是有前途的. 这种方法可能会为骨髓瘤患者带来新的组合免疫疗法.
科学领域:
- 在瘤学瘤学.
- 细胞死亡机制 细胞死亡机制
- 免疫治疗是一种免疫疗法.
背景情况:
- 骨髓瘤 (OS) 是一种具有不良预后的侵袭性骨癌,特别是在耐标准治疗的患者中.
- 迫切需要新的治疗策略,因为OS的生存率停滞不前.
- 铁亡是一种受调节的细胞死亡形式,由于其对铁的依赖性和克服药物耐药性的作用,它对OS具有潜在的脆弱性.
研究的目的:
- 审查骨髓瘤中铁亡的调节网络.
- 探索铁和瘤免疫微环境 (TME) 之间的相互作用.
- 讨论基于ferroptosis的疗法在OS中的临床转化所面临的挑战和机遇.
主要方法:
- 综合性文献综述,重点关注OS中的铁亡途径.
- 对系统Xc-/氨酸氧化酶4 (GPX4) 轴和脂质代谢在铁死中的分析.
- 检查铁亡对TME内的免疫细胞的影响,包括树突细胞,CD8+ T细胞,瘤相关巨细胞 (TAMs) 和调控性T细胞 (Tregs).
主要成果:
- 在OS细胞中诱导铁亡可以克服对传统疗法的抗性.
- 铁亡会触发免疫细胞死亡 (ICD),并增强抗瘤免疫反应.
- 铁酶通过调节免疫细胞极化和功能来影响TME,可能减少免疫抑制.
结论:
- 铁死在骨髓瘤中提供了明显的治疗脆弱性.
- 向铁死可以与免疫疗法协同作用,以增强抗瘤效应.
- 临床翻译需要解决瘤异质性,毒性等挑战,并开发预测生物标志物和传递系统.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.6K
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11.1K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
